ConductScience.org, home

Paper38947210

Bioreversible Anionic Cloaking Enables Intracellular Protein Delivery with Ionizable Lipid Nanoparticles.

Alamgir A and 3 others. ACS Cent Sci, 2024. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Bioreversible Anionic Cloaking Enables Intracellular Protein Delivery with Ionizable Lipid Nanoparticles. Papers, record 38947210. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38947210

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bioreversible Anionic Cloaking Enables Intracellular Protein Delivery with Ionizable Lipid Nanoparticles.
PubMed
Journal
ACS Cent Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
1.97, provisional
iCite
Revised in PubMed
2025-04-05
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alamgir AAzmain
2Ghosal SSouvik
3DeLisa MPMatthew Phttps://orcid.org/0000-0003-3226-1566
4Alabi CAChristopher Ahttps://orcid.org/0000-0003-2654-018X

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
S10 OD032251NIH HHSUnited StatesS10OD032251PubMed

Source NIH RePORTER

Download CSV of grants

References46

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126702034Gene therapy: progress and predictions.Proc Biol Sci2015https://conductscience.org/library/papers/26702034PubMed
2365968582022 FDA approvals.Nat Rev Drug Discov2023https://conductscience.org/library/papers/36596858PubMed
321572409A roadmap to generate renewable protein binders to the human proteome.Nat Methods2011https://conductscience.org/library/papers/21572409PubMed
435346768The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs.J Control Release2022https://conductscience.org/library/papers/35346768PubMed
523664777ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering.Trends Biotechnol2013https://conductscience.org/library/papers/23664777PubMed
632251383Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing.Nat Nanotechnol2020https://conductscience.org/library/papers/32251383PubMed
725357182Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo.Nat Biotechnol2015https://conductscience.org/library/papers/25357182PubMed
821154794Drug delivery using nanoparticle-stabilized nanocapsules.Angew Chem Int Ed Engl2011https://conductscience.org/library/papers/21154794PubMed
934421476Nanogel-facilitated Protein Intracellular Specific Degradation through Trim-Away.Adv Funct Mater2021https://conductscience.org/library/papers/34421476PubMed
1011818562Probing protein conformational changes in living cells by using designer binding proteins: application to the estrogen receptor.Proc Natl Acad Sci U S A2002https://conductscience.org/library/papers/11818562PubMed
1131206027A boronic acid-rich dendrimer with robust and unprecedented efficiency for cytosolic protein delivery and CRISPR-Cas9 gene editing.Sci Adv2019https://conductscience.org/library/papers/31206027PubMed
129065401Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma.Science1997https://conductscience.org/library/papers/9065401PubMed
1333034131Synergistic Interplay of Covalent and Non-Covalent Interactions in Reactive Polymer Nanoassembly Facilitates Intracellular Delivery of Antibodies.Angew Chem Int Ed Engl2021https://conductscience.org/library/papers/33034131PubMed
1437115558Lipid Nanoparticle Delivery of Small Proteins for Potent In Vivo RAS Inhibition.ACS Appl Mater Interfaces2023https://conductscience.org/library/papers/37115558PubMed
1536920197Modular Diazo Compound for the Bioreversible Late-Stage Modification of Proteins.J Am Chem Soc2023https://conductscience.org/library/papers/36920197PubMed
1633199717The once and future gene therapy.Nat Commun2020https://conductscience.org/library/papers/33199717PubMed
1726192320Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown.Nat Biotechnol2015https://conductscience.org/library/papers/26192320PubMed
1829808576Bioinspired Diselenide-Bridged Mesoporous Silica Nanoparticles for Dual-Responsive Protein Delivery.Adv Mater2018https://conductscience.org/library/papers/29808576PubMed
1927474402Virus-like particles as drug delivery vectors.Acta Biochim Pol2016https://conductscience.org/library/papers/27474402PubMed
2027274052PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer.Proc Natl Acad Sci U S A2016https://conductscience.org/library/papers/27274052PubMed

See all 46 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
42677397Protein Modifications for Cellular Protein Delivery.Chem Rev2026https://conductscience.org/library/papers/42677397PubMed
42293396Polyelectrolyte nanoparticles enable intracellular delivery of STING protein fragments for ovarian cancer immunotherapy.Mater Today Bio2026https://conductscience.org/library/papers/42293396PubMed
41942053Therapeutic peptides and proteins: Status and developments in drug delivery.J Control Release2026https://conductscience.org/library/papers/41942053PubMed
41146908Anionic lipids direct efficient microfluidic encapsulation of stable and functionally active proteins in lipid nanoparticles.Commun Mater2025https://conductscience.org/library/papers/41146908PubMed
40704024Combined cancer immunotherapy with lipid nanoparticle delivery of oligo-based cGAS-agonistic adjuvant and peptide or mRNA vaccines.Mol Ther Nucleic Acids2025https://conductscience.org/library/papers/40704024PubMed
40619768Carriers Multimerize STING Protein Fragments to Activate Type I Interferon Signaling in STING-Deficient Cancer Cells.Mol Pharm2025https://conductscience.org/library/papers/40619768PubMed
40430958Novel Delivery of Cyclic-Diguanylate Monophosphate Utilizing Amyloid Depots.Pharmaceutics2025https://conductscience.org/library/papers/40430958PubMed
40324952Nanoparticle-Mediated Targeted Protein Degradation: An Emerging Therapeutics Technology.Angew Chem Int Ed Engl2025https://conductscience.org/library/papers/40324952PubMed
40056044Optimization of Lipid Nanoparticles with Robust Efficiency for the Delivery of Protein Therapeutics to Augment Cancer Immunotherapy.Adv Sci (Weinh)2025https://conductscience.org/library/papers/40056044PubMed
39206956Chemoselective Reagents for the Traceless Bioreversible Modification of Native Proteins.Bioconjug Chem2024https://conductscience.org/library/papers/39206956PubMed
39201377Drug Delivery Strategies for Age-Related Diseases.Int J Mol Sci2024https://conductscience.org/library/papers/39201377PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
RNASE16035PubTator's text mininghttps://conductscience.org/library/genes/6035NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38947210

GET https://conductscience.org/api/papers/v1/38947210/references?page=2